142.68MUSD
See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US0144421072
CUSIP
014442107
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
1.28
Dividend Share
-
Dividend Yield
-
Earnings Share
-1.23
Wall Street Target Price
4.22
EPS Estimate Current Year
-1.97
EPS Estimate Next Year
-1.34
EPS Estimate Current Quarter
-0.5443
EPS Estimate Next Quarter
-0.42
Most Recent Quarter
-
Revenue TTM
100,558,000
Gross Profit TTM
-85,382,000
EBITDA
-137,384,992
Profit Margin
-118.39%
Return On Assets TTM
-16.37%
Return On Equity TTM
-91.24%
Revenue Per Share TTM
1.041
Qtly Revenue Growth YOY
257.10%
Diluted Eps TTM
-1.23
Qtly Earnings Growth YOY
-86.30%
Trailing PE
0.00
Forward PE
526
Price Sales TTM
1.3795
Price Book MRQ
1.0862
Enterprise Value Revenue
2
Enterprise Value EBITDA
-8
98.50
6.14%244.99
2.61%591.45
1.76%100.00
1.71%249.00
1.34%494.74
1.33%78.89
0.66%184.83
0.00%689.50
-3.89%155.48
-0.30%